Molecular mechanisms of striatal gene regulation: A critical role for glutamate in dopamine-mediated gene induction

Pharmacological Regulation of Gene Expression in the CNS

Volumn , Issue , 2017, Pages 115-134

  Hyman, Steven E ^a   Cole, Rebecca L ^a   Schwarzschild, Michael ^a   Cole, Douglas ^a   Hope, Bruce ^a   Konradi, Christine ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0012767447     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203711149     Document Type: Chapter

References (58)

1. Hyman, S. E. and Nestler, E. The Molecular Basis of Psychiatry. American Psychiatric Association, Washington, D.C., 1993.
2. Graybiel, A. M., Moratalla, M. R., and Robertson, H. A., Amphetamine and cocaine induce drug specific activation of the c-fos gene in striasome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U.S.A., 87, 6912, 1990.
3. Young, S. T., Porrino, L. J., and Iadarola, M. J., Cocaine induces striatal c-os-im-munoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. U.S.A., 88, 291,1991.
4. Nguyen, T. V., Kosofsky, B., Birnbaum, R., Cohen, B. M., and Hyman, S. E., Differential expression of c-fos and zif 268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. U.S.A., 89, 4270, 1992.
5. Gerfen, C. R., Keefe, K. A., and Gauda, E. B., D1 and D2 dopamine receptor function in striatum: Co-activation of Dl- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in Dl-containing neurons. J. Neurosci., 15:8167, 1995.
6. Wang, J. Q., Daunais, J. B., and McGinty, J. F., NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse, 18, 343, 1994.
7. Snyder-Keller, A.M., Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena. Exp. Neurol., 113, 155, 1991.
8. Konradi, C., Cole, R. L., Senatus, P, Leveque, J. C., Pollack, A., Grossband, S. J., and Hyman, S. E., Analysis of proenkephalin second messenger-inducible enhancer in rat striatal cultures. J. Neurochem., 65, 1007, 1995.
9. Kebabian, J. B. and Caine, D. B., Multiple receptors for dopamine. Nature, TJ1, 93, 1979.
10. Monsma, F. J., Mahan, L. C., Vittie, L. D., Gerfen, C. R., and Sibley, D. R., Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc. Natl. Acad. Sci. U.S.A., 87, 6723, 1990.
11. Surmeier, D. J., Bargas, J., Hemmings, H. C., Jr., Nairn, A. C., and Greengard, R, Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron, 14, 385, 1995.
12. Montminy, M. R. and Bilezikjian, L. M., Binding a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature, 328, 175, 1987.
13. Gonzalez, G. A. and Montminy, M. R., Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell, 59, 675, 1989.
14. Molina, C. A., Foulkes, N. S., Lalli, E., and Sassone-Corsi, P, Inducibility and negative autoregulation of CREM: an alternative promotor directs the expression of ICER and early response repressor. Cell, 74, 875, 1993.
15. Sheng, M., Thompson, M. A., and Greenberg, M. E., CREB: a Ca (2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science, 252, 1427, 1993.
16. Dash, R, Karl, K. A., Colicos, M.A.C., Prywes, R., and Kandel, E. R., cAMP response element-binding protein is activated by Ca2+/ Calmodulin as well as cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A., 88, 5061, 1991.
17. Bonni, A., Ginty, D. D., Dudek, FI., and Greenberg, M. E., Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neUrotrophin signals. Mol. Cell. Neurosci., 6, 168, 1995.
18. 17a. Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., and Sibley, D. R., D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science, 250, 1429, 1990.
19. Gerfen, C. R., McGinty, J. F., and Young III, W. S., Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurochem., 11, 1061, 1991.
20. Le Moine, C., Normand, E., and Guitteny, A. F. et al., Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natl. Acad. Sci. U.S.A., 87, 230, 1990.
21. Yung, K. K. L., Bolam, J. R, Smith, A. D., Hersch, S. M., Liliax, B. J., and Levey, A. I., Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience, 65, 709-730.
22. Hope, B., Kosofsky, B., and Hyman, S. E., and Nestler, E., Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci. U.S.A., 89, 5764, 1992.
23. Moratalla, R., Robertson, H. A., and Graybiel, A. M., Dynamic regulation of NGFI-A (zif268, egrl) gene expression in the striatum. J. Neurosci., 12, 2609, 1992.
24. Kosofsky, B. E., Genova, L. M., and Hyman, S. E., Postnatal age defines specificity of immediate early gene induction by cocaine in developing rat brain. J. Comp. Neurol., 351, 27, 1995.
25. Kosofsky, B. E., Genova, L. M., and Hyman, S. E., Substance P phenotype defines specificity of c-fos induction by cocaine in developing rat striatum. J. Comp. Neurol., 351, 41, 1995.
26. Jaber, M., Cador, M., Dumartin, B., Normand, E., Stinus, L., and Bloch, B., Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and fos immunoreactivity in rat striatal neurons. Neuroscience, 64, 1041, 1995.
27. 25a. Sivam, S. P, Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J. Pharmacol. Exp., 256, 818, 1989.
28. Smiley, P. L., Johnson, M., and Bush, L. et al., Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp., 253, 938, 1990.
29. Steiner, H. and Gerfen, C. R., Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression.]. Neurosci., 13, 5066, 1993.
30. Li, S. J., Sivam, S. P., and McGinty, J. F. et al., Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J. Pharmacol. Exp. Ther., 246, 403, 1988.
31. Smith, A. J. W. and McGinty, J. F., Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Mol. Brain Res., 21, 359, 1994.
32. Hurd, Y. L., Brown, E. E., Finlay, J. M., Fibiger, H. C., and Gerfen, C. R., Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res., 13, 165-170, 1992.
33. Daunais, J. B., Roberts, D. C. S., and McGinty, J. F., Cocaine self-administration increases preprodynorphin, but not c-fos mRNA in rat striatum. NeuroReport, 4, 543, 1993.
34. Hurd, Y. L. and Herkenham, M., Molecular alterations in the neostriatum of human cocaine addicts. Synapse, 13, 357, 1993.
35. Xu, M., Moratalla, R., Gold, L. H., Hiroi, N., Koob, G. F., Graybiel, A. M., and Tonegawa, S., Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell, 79, 729, 1994.
36. Krebs, M. O., Gauchy, C., Desban, M., Glowinski, J., and Kernel, M. L., Role of dynorphin and GABA in the inhibitory regulation of NMDA-induced dopamine release in striosome and matrix-enriched areas of the rat striatum. J. Neurosci., 14, 2435, 1994.
37. Steiner, H. and Gerfen, C. R., Dynorphin opioid inhibition of cocaine-induced D1 dopamine receptor-mediated immediate-early gene expression in the striatum. /. Comp. Neurol, 353, 200, 1995.
38. Chavkin, C., James, I. F., and Goldstein, A., Dynorphin is a specific endogenous ligand for k-opioid receptor. Science, 215, 413, 1982.
39. Corbett, A. D., Paterson, S. J., McKnight, A. T., Magnan, J., and Kosterlitz, H. W., Dynorphin 1-8 and dynorphin 1-9 are ligands for the kappa-subtype of opiate receptor. Nature, 299, 79, 1982.
40. Bals-Kubik, R., Ableitner, A., and Herz, A., Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther., 264, 489, 1993.
41. Spanagel, R., Herz, A., and Shippenberg, T. S., Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A., 89:2046, 1992.
42. Douglass, J., McKinzie, A. A., and Pollock, K. M., Identification of multiple DNA elements regulating basal and protein kinase: A-induces transcriptional expression of the rat prodynorphin gene. Mol. Endocrinol, 8, 333, 1994.
43. Naranjo, J. R., Mellstrom, B., and Achaval, M. et al., Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron, 6, 607, 1991.
44. Cole, R.L., Konradi, C., Douglass J., Hyman, S. E., Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron, 14, 813, 1995.
45. Kashihara, K., Hamamura, T., Okumura, K., and Otsuki, S., Effect of MK-801 on endogenous dopamine release in vivo. Brain Res., 528, 80, 1990.
46. Konradi, C., Cole, R. L., Heckers, S., and Hyman, S. E., Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci., 14, 5623, 1994.
47. Krebs, M. O., Desce, J. M., Kernel, M. L., Gauchy, C., Godeheu, G., Cheramy, A., and Glowinski, J., Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem., 56, 81, 1991.
48. Johnson, K. M. and Jeng, Y. J., Pharmacological evidence for N-methyl-D-aspartate receptors on nigrostriatal dopaminergic nerve terminals. Can. J. Physiol. Pharmacol., 69, 1416, 1991.
49. Konradi, C, Leveque, J. C, and Hyman, S. E., Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium, J. Neurosci., 16, 1996.
50. Sheng M., McFadden, G., and Greenberg, M. E., Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron, 4, 571, 1990.
51. Ginty, D. D., Kornhauser, J. M., and Thompson, M. A. et al., Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and circadian clock. Science, 260, 238, 1993.
52. Hope, B. T., Nye, H. E., Kelz, M. B., Self, D. W., Iadarola, M. J., Nakabeppu, Y., Duman, R. S., and Nestler, E., Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in the brain by chronic cocaine and other chronic treatments. Neuron, 13, 1235, 1994.
53. Konradi, C., Kobierski, L., and Nguyen, T. V. et al., The cAMP-response-elementbinding protein interacts, but Fos protein does not interact with the proenkephalin enhancer in rat striatum, Proc. Natl. Acad. Sci. U.S.A., 90, 7005, 1994.
54. Sassone-Corsi, R, Visvader, J., and Ferland, L. et al., Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev., 2, 529, 1988.
55. Karin, M., The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem., 270, 1235, 1995.
56. Sanchez, I., Hughes, R. T., and Mayer, B. J. et al., Role of SAPK ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature, 372, 794, 1994.
57. Cepeda, C. N.A. B., and Levine, M. S., Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated, Proc. Natl. Acad. Sci. U.S.A., 90, 9576, 1993.
58. Wolf, M. E., White, F. J., and Hu, X. T., MK-801 prevents alterations in the mesoac-cumbens dopamine system associated with behavioral sensitization to amphetamine. J. Neurosci., 14:1735-1745, 1994.